Article Type

376 - 390 of 1392 Results       Clear All

Omicron Subvariants BA.4, BA.5 Are Spreading ‟Like Wildfire”, Becoming Dominant Strains in US

Gladstone in the News June 30, 2022

Omicron Subvariants BA.4, BA.5 Are Spreading ‟Like Wildfire”, Becoming Dominant Strains in US

ABC7 News—As Omicron BA.4 and BA.5 variants overtake previous coronavirus variants across the United States, Gladstone Associate Investigator Nadia Roan, PhD, explains that their success may owe both to their ability to escape our immune system and to their accelerated replication rate. She suggests that more effort should be made to block infection at the level of the airways, the virus's entry point into our body.

Gladstone Experts COVID-19 Roan Lab

Cancer Research Institute Names Newest Class of Lloyd J. Old STARs, Today’s Visionaries in Cancer Immunotherapy Research

Gladstone in the News June 22, 2022

Cancer Research Institute Names Newest Class of Lloyd J. Old STARs, Today’s Visionaries in Cancer Immunotherapy Research

Cancer Research Institute—The Cancer Research Institute recently announced its newest cohort of Scientists Taking Risks (STAR) funding for high risk/high reward research in tumor biology. Of the six recipients, three are core members of the Gladstone-UCSF Institute of Genomic Immunology: Kole Roybal, Ansuman Satpathy, and Matthew Spitzer.

Awards Gladstone Experts Genomic Immunology

Why We’re Still Living With ‘Wily’ COVID a Year After California’s Reopening

Gladstone in the News June 14, 2022

Why We’re Still Living With ‘Wily’ COVID a Year After California’s Reopening

San Francisco Chronicle—A year has passed since California dropped most public health restrictions related to COVID-19, but the pandemic isn’t over. Senior Investigator Warner Greene notes that the virus is still spreading effectively, and people can be infected repeatedly with different subvariants.

Gladstone Experts COVID-19 Infectious Disease Greene Lab

Fever, Body Aches, Loss of Smell: New COVID Study Charts Evolution of Symptoms

Gladstone in the News May 29, 2022

Fever, Body Aches, Loss of Smell: New COVID Study Charts Evolution of Symptoms

San Francisco Chronicle—A study in the Mission District of San Francisco tracked how COVID-19 symptoms have changed over the course of the pandemic. Gladstone virologist Nadia Roan explains that the Omicron variant infects the upper respiratory tract and triggers a localized immune response, which may in part explain why individuals infected during the Omicron wave were less likely to experience severe illness.

Gladstone Experts COVID-19 Infectious Disease Roan Lab

Covid Was Vanishing Last Memorial Day. Cases Are Five Times Higher Now.

Gladstone in the News May 28, 2022

Covid Was Vanishing Last Memorial Day. Cases Are Five Times Higher Now.

Washington Post—Even as COVID restrictions are easing, case numbers are rising around the country. Melanie Ott, director of the Gladstone Institute of Virology, explains that recent research from her group shows that individuals infected with the Omicron variant have limited natural immunity, and may still be susceptible to infection with Omicron subvariants.

Gladstone Experts COVID-19 Infectious Disease Ott Lab

Scientists Explain Why Getting Infected With Omicron Doesn’t Protect You From Other COVID Variants

Gladstone in the News May 20, 2022

Scientists Explain Why Getting Infected With Omicron Doesn’t Protect You From Other COVID Variants

ABC News—Gladstone virologists investigated the effect of the Omicron variant on the immune response. Melanie Ott describes her team’s discovery that previous infection with Omicron does not result in strong immunity to other known SARS-CoV-2 variants. However, as Nadia Roan explains, individuals who were vaccinated before becoming infected with Omicron did have a broadly protective immune response, emphasizing the importance of the vaccines in saving lives.

Gladstone Experts COVID-19 Infectious Disease Doudna Lab Greene Lab Ott Lab Roan Lab

UCSF Awarded $67.5 Million to Develop New Antiviral Therapies

Gladstone in the News May 18, 2022

UCSF Awarded $67.5 Million to Develop New Antiviral Therapies

UCSF News—Nevan Krogan, PhD, a senior investigator at Gladstone and the director of the Quantitative Biosciences Institute at UC San Francisco, leads a vast, international collaborative effort to find drugs against COVID-19 called the QBI Coronavirus Research Group (QCRG). The group recently received $67.5 million from the National Institutes of Health, the largest such award in UCSF's history, to pursue work on coronaviruses and other viruses with pandemic potential.

Gladstone Experts COVID-19 Data Science and Biotechnology Krogan Lab

More News

Are You a Journalist Looking to Write about Gladstone?

Explore Info for Media